Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-009873
Date:2023-02-13
Issuer: VERA THERAPEUTICS, INC. (VERA)
Original Submission Date:

Reporting Person:

SEIDENBERG BETH C
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120 BRISBANE, CA 94005

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2023-02-13 P 10,072 a $7.20 1,664,702 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the shares were purchased as follows: 9,739 shares by kleiner perkins caufield & byers xvi, llc ("kpcb xvi") and 333 shares by kpcb xvi founders fund, llc ("xvi founders"). all shares are held for convenience in the name of "kpcb holdings, inc., as nominee". the managing member of kpcb xvi and xvi founders is kpcb xvi associates, llc ("xvi associates"). l. john doerr, beth seidenberg, randy komisar, theodore e. schlein and wen hsieh, the managing members of xvi associates, exercise shared voting and dispositive control over the shares held by kpcb xvi and xvi founders. such managing members disclaim beneficial ownership of all shares held by kpcb xvi and xvi founders except to the extent of their pecuniary interest therein.
f2 represents weighted average purchase price. the shares were purchased at prices ranging from $7.1096 to $7.2500. the reporting person will provide upon request, to the sec, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
f3 consists of 1,609,603 shares of class a common stock held by kpcb xvi and 55,099 shares of class a common stock held by xvi founders.
WhaleWisdom Logo

Elevate your investments